Neoadjuvant Chemoradiation Therapy With Oxaliplatin and Capecitabine for Patients With Surgically Resectable Gastric Cancer: A Pilot Phase II Trial With Molecular Correlates.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Oxaliplatin
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 17 Aug 2012 Biomarkers information updated
- 16 Aug 2012 Actual end date (1 Apr 2009) added as reported by ClinicalTrials.gov.
- 04 Jan 2008 Status changed from recruiting to in progress.